EMC Insurance Group Inc. (EMCI) Drops 5.14% on January 12

Equities Staff  |

EMC Insurance Group Inc. (EMCI) was one of the Russell 2000's biggest losers for Tuesday January 12 as the stock slid 5.14% to $22.64, a loss of $-1.227 per share. Starting at an opening price of $23.95 a share, the stock traded between $22.51 and $24.45 over the course of the trading day. Volume was 37,760 shares over 263 trades, against an average daily volume of 24,808 shares and a total float of 20.75 million.

The losses send EMC Insurance Group Inc. down to a market cap of $469.76 million. In the last year, EMC Insurance Group Inc. has traded between $26.83 and $19.84, and its 50-day SMA is currently $25.38 and 200-day SMA is $23.99.

The stock has a P/E Ratio of 8.7.

EMC Insurance Group Inc conducts its operations in property and casualty insurance and reinsurance through its subsidiaries. It is engaged in the sale of commercial lines of property and casualty insurance to small and medium-sized businesses.

EMC Insurance Group Inc. is based out of Des Moines, IA and has some 2,143 employees. Its CEO is Bruce G. Kelley.

For a complete fundamental analysis analysis of EMC Insurance Group Inc., check out Equities.com’s Stock Valuation Analysis report for EMCI. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










Level Headed at World Crypto Con - Steve Beauregard

Bloq.com CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.